Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

NCT04061109 ·Status: UNKNOWN ·Phase: PHASE3

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A

NCT04845399 ·Status: COMPLETED ·Phase: PHASE3

Gene Therapy for Haemophilia A.

NCT03001830 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

NCT04456387 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

NCT01125813 ·Status: COMPLETED ·Phase: PHASE3

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

NCT03528551 ·Status: COMPLETED ·Phase: PHASE3

Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A

NCT03818763 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients

NCT00157157 ·Status: COMPLETED ·Phase: PHASE3

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

NCT01712438 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

NCT04060836 ·Status: UNKNOWN ·Phase: PHASE1

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

NCT00989196 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A

NCT06833983 ·Status: RECRUITING ·Phase: PHASE3

A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

NCT03855696 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

NCT00782470 ·Status: COMPLETED

A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

NCT05265286 ·Status: COMPLETED ·Phase: PHASE2

Study of a Gene Therapy Treatment for Hemophilia A

NCT06297486 ·Status: WITHDRAWN ·Phase: PHASE3

Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A

NCT01790828 ·Status: COMPLETED

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

NCT02396862 ·Status: COMPLETED

Safety and Efficacy Study of NGGT003 in Hemophilia A Patients

NCT06238908 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Lentiviral FVIII Gene Therapy

NCT03217032 ·Status: RECRUITING ·Phase: PHASE1

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

NCT02172950 ·Status: COMPLETED ·Phase: PHASE3

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

NCT02576795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A

NCT02930317 ·Status: UNKNOWN ·Phase: PHASE3